Skip to main
MODV
MODV logo

ModivCare (MODV) Stock Forecast & Price Target

ModivCare (MODV) Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 20%
Buy 20%
Hold 60%
Sell 0%
Strong Sell 0%

Bulls say

ModivCare Inc. demonstrated a positive trajectory with a 192 basis point increase in utilization of its non-emergency medical transportation (NEMT) services, reaching 10.8% during the reported quarter. Additionally, the personal care services (PCS) segment achieved a top-line revenue growth of 3.0%, supported by a 3.5% increase in revenue per hour, resulting in improved overall margins of 5.7% compared to the previous year. The adjusted EBITDA margin increased by 65 basis points year-over-year, reaching 9.4%, highlighting the company's focus on operational efficiency and anticipated benefits from a growing fee-for-service contracting mix.

Bears say

ModivCare Inc. is facing significant financial challenges, highlighted by a projected top-line decline of approximately 6.7% in its NEMT business for 2025, primarily due to a $200 million revenue headwind from contract attrition. The company's RPM segment reported adjusted EBITDA of $6.8 million, falling short of expectations and reflecting softened margins of around 35.4%. Additionally, the remote monitoring revenue experienced a decline of 5.3%, alongside a 7.4% decrease in the Matrix business revenue, contributing to ongoing financial instability.

ModivCare (MODV) has been analyzed by 5 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 20% recommend Buy, 60% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of ModivCare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About ModivCare (MODV) Forecast

Analysts have given ModivCare (MODV) a Buy based on their latest research and market trends.

According to 5 analysts, ModivCare (MODV) has a Buy consensus rating as of Sep 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.70, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.70, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

ModivCare (MODV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.